• Contact Us
Pharmaceuticals & Life Sciences Blogs - VWV

Pharma & Life Sciences

Articles & Blogs Pharma & Life Sciences

What remedy is left for contract breach after Court gives wide exclusion of liability for anticipated profits?

Monday, 03 March 2025

Parties to commercial contracts often include exclusion clauses to manage their liability risks. This may contain a list of items such as lost profits, lost revenue, and lost savings among other items.

What remedy is left for contract breach after Court gives wide exclusion of liability for anticipated profits?
Read More >

Articles & Blogs Pharma & Life Sciences

Sustainability trends: key issues shaping the future of Pharmaceuticals and Life Sciences

Monday, 03 March 2025

Leaders in net zero certification, Planet Mark, have recently identified the key sustainability trends for businesses in the UK and beyond. What do these trends mean for the Pharmaceuticals and Life Sciences sector?

Sustainability trends: key issues shaping the future of Pharmaceuticals and Life Sciences
Read More >

Articles & Blogs Pharma & Life Sciences

AI - a tool for sustainability with a resource cost

Thursday, 06 February 2025

AI's sustainability remains a nuanced question, balancing its potential benefits against its environmental costs.

AI - a tool for sustainability with a resource cost
Read More >

Articles & Blogs Pharma & Life Sciences

COP29: What are the key points for the Pharmaceuticals and Life Sciences sector?

Thursday, 06 February 2025

COP29, the 29th Conference of the Parties to the United National Framework Convention on Climate Changes (UNFCCC), was held between 11 and 24 November 2024. We consider the key points for the Pharmaceuticals and Life Sciences sector.

COP29: What are the key points for the Pharmaceuticals and Life Sciences sector?
Read More >

Articles & Blogs Pharma & Life Sciences

Why must Pharma act on sustainability now?

Thursday, 06 February 2025

Even only a couple of years ago, sustainability was seen as something that would be a 'nice to have'. No more. It has risen right up to the top of the agenda as a leading issue for pharma leaders. Why? The pressure has been coming from lots of angles.

Why must Pharma Act on sustainability now?
Read More >

Articles & Blogs Pharma & Life Sciences

What can we expect from the new era of clinical trials in the UK?

Thursday, 23 January 2025

It is hoped that changes to legislation on clinical trials in the UK will quicken the trial approvals process and foster innovation in trial design without compromising patient safety. The amending legislation has been made and will apply in early 2026.

What can we expect from the new era of clinical trials in the UK?
Read More >

Articles & Blogs Pharma & Life Sciences

Changes to UK medical devices regulation: What is on the horizon for 2025?

Thursday, 23 January 2025

The Medicines and Healthcare products Regulatory Agency (MHRA) recently published a roadmap which sets out the revised timeline for implementing reforms to the UK's medical devices regulatory framework.

Changes to UK medical devices regulation: What is on the horizon for 2025?
Read More >

Articles & Blogs Pharma & Life Sciences

Economic Crime and Corporate Transparency Act 2023 - managing fraud risk and the failure to prevent offence

Thursday, 23 January 2025

The Economic Crime and Corporate Transparency Act 2023 (the Act) is a pivotal piece of legislation, aimed at bolstering the UK's defences against fraud.

Economic Crime and Corporate Transparency Act 2023 - managing fraud risk and the failure to prevent offence
Read More >

Articles & Blogs Pharma & Life Sciences

Pharmaceuticals and Life Sciences: what will 2025 bring?

Thursday, 12 December 2024

As things quieten down for the end of the year (ha ha, one day maybe but not 2024!), it is good to reflect on what is next. In this article, we have pointed towards a few key developments to watch out for in 2025.

Pharmaceuticals and Life Sciences: what will 2025 bring?
Read More >

Articles & Blogs Pharma & Life Sciences

Court of Appeal rules on how to calculate damages in liability clause

Thursday, 12 December 2024

Clarifying liability caps: Key lessons from the Topalsson v Rolls Royce case

Court of Appeal rules on how to calculate damages in liability clause
Read More >

Articles & Blogs Higher Education Pharma & Life Sciences

Research and development subsidies - report into the £129 million grant funding to BioNTech for the life sciences sector

Monday, 02 December 2024

This blog examines the Subsidy Advice Unit (SAU) report into a proposed subsidy by the Department of Science Innovation and Technology (DSIT) to BioNTech UK Limited (BioNTech).

Research and development subsidies - report into the £129 million grant funding to BioNTech for the life sciences sector
Read More >

Articles & Blogs Pharma & Life Sciences

Life Sciences and sustainability shine in new UK industrial strategy

Tuesday, 19 November 2024

"Growth is the number one mission of this government. Our new Industrial Strategy is central to that Growth Mission". So starts the Green Paper setting out the new UK Government's vision for an Industrial Strategy that plans to 2035 and beyond.

Life Sciences and sustainability shine in new UK industrial strategy
Read More >

Articles & Blogs Pharma & Life Sciences

Protecting data: implications of the Cyber Security and Resilience Bill for the UK's pharmaceuticals and life sciences sector

Tuesday, 19 November 2024

The proposed Cyber Security and Resilience Bill (the Bill) intends to capture more sectors, increase incident reporting and strengthen ICO powers - we consider the potential implications for the UK's pharmaceuticals and Life Sciences sector.

Protecting data: implications of the Cyber Security and Resilience Bill for the UK's pharmaceuticals and life sciences sector
Read More >

Articles & Blogs Pharma & Life Sciences

AI and copyright - moving closer to a solution?

Tuesday, 19 November 2024

Lawmakers are addressing how to govern the use of copyrighted materials for training AI models. This article examines the situation in the UK and Europe.

AI and copyright - moving closer to a solution?
Read More >

Articles & Blogs Pharma & Life Sciences

Poorly drafted no assignment clause did not stop novation by conduct

Friday, 18 October 2024

A contractual clause prohibiting assignment without the other party's prior written consent did not stop the novation (ie replacement) of one of the parties by another party, the High Court has ruled.

Poorly drafted no assignment clause did not stop novation by conduct
Read More >